A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
Clinical trial NCT01008995 · COMPLETED
Trial details
- NCT number
- NCT01008995
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.